Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Christian G. Hartinger(University of Auckland), Nils Metzler‐Nolte(Ruhr University Bochum), Paul J. Dyson(École Polytechnique Fédérale de Lausanne)
Cited by 554Open Access
Abstract
This review provides an introduction into the fascinating area of organometallic anticancer compounds. Although the subject dates back many years, it has witnessed considerable growth only in the past decade. A brief overview of the subject together with recent pertinent examples is provided. The properties of organometallic compounds that lend themselves to medical applications, the main current approaches used, and possible avenues for future research are identified.
Related Papers
No related papers found
Powered by citation graph analysis